Case report: Disseminated herpes simplex virus 1 infection and hemophagocytic lymphohistiocytosis after immunomodulatory therapy in a patient with coronavirus disease 2019

Case report: Disseminated herpes simplex virus 1 infection and hemophagocytic lymphohistiocytosis after immunomodulatory therapy in a patient with coronavirus disease 2019

Corticosteroids and immunomodulatory therapies are widely used to treat patients with severe coronavirus disease 2019 (COVID-19). Janus kinase (JAK) inhibitors such as tofacitinib have been recently studied as adjuvants in the treatment of COVID-19. Although immunomodulatory therapies may be linked...

Full description

Bibliographic Details
Main Authors: Elvio Mazzotta, Juan Fiorda Diaz, Marco Echeverria-Villalobos, Gregory Eisinger, Sarah Sprauer, Arindam Singha, Michael R. Lyaker
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Medicine
Subjects:
human herpes simplex virus 1
COVID-19
liver failure
hemophagocytic lymphohistiocytosis
tofacitinib
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1053012/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.1053012/full

Similar Items